SCHEMBL20908413

SCHEMBL20908413

CC(=O)NCC1CCC(CBr)O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 3/20 0.40
▸ FUCA1 P04066 1/20 0.34
▸ GLA P06280 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CACNA1H O95180 1/20 0.31
▸ FAP Q12884 2/20 0.31
▸ DPP4 P27487 1/20 0.31
▸ PREP P48147 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ MTNR1B P49286 1/20 0.31
▸ RAB9A P51151 1/20 0.30
▸ ALPL P05186 1/20 0.30
▸ ALPI P09923 1/20 0.30
▸ ALPG P10696 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ HIF1A Q16665 1/20 0.30
▸ TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20908631 0.83 MTNR1A (0.41) MTNR1AFUCA1GLANPSR1CACNA1H
SCHEMBL20908630 0.83 MTNR1A (0.41) MTNR1AFUCA1GLANPSR1CACNA1H
SCHEMBL6936974 0.75 MTNR1A (0.38) MTNR1AFUCA1GLAL3MBTL1SMN1; SMN2
SCHEMBL31677770 0.72 — —
SCHEMBL19744356 0.72 — —
SCHEMBL19744410 0.72 — —
SCHEMBL19744405 0.72 — —
SCHEMBL12968045 0.71 MTNR1A (0.38) MTNR1AFUCA1
SCHEMBL17475497 0.71 CYP2D6 (0.42) L3MBTL1USP2SMN1; SMN2RAB9AALPL
SCHEMBL4663635 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019074887-A1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2019-04-18 — — WO disclosed
Send feedback